HOUSE 796119th CongressReferred to the House Committee on Energy and Commerce.
Expressing support for the designation of October 9 through October 16, 2025, as "National Dyspraxia/Developmental Coordination Disorder (DCD) Awareness Week" and a commitment to raise awareness of dyspraxia/DCD in the United States.
- Last Action
- 10/8/2025
Actions
- 2025-01-28Referred to the House Committee on Energy and Commerce.
- 2025-01-28Introduced in House
- 2025-01-28Introduced in House
CRS Summary
As of 2025-01-28 (00)
Second Chance for Moms Act of 2025
This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Cosponsors (13)
- Brian Babin (R-TX)
- Barry Moore (R-AL)
- Riley Moore (R-WV)
- Andrew Ogles (R-TN)
- Daniel Webster (R-FL)
- Claudia Tenney (R-NY)
- Andrew Clyde (R-GA)
- Andy Harris (R-MD)
- Randy Weber (R-TX)
- Mark Harris (R-NC)
- Gary Palmer (R-AL)
- John Rose (R-TN)
- Sheri Biggs (R-SC)
Subjects
- Abortion
- Consumer affairs
- Prescription drugs
- Sex and reproductive health
- Telephone and wireless communication
- Women's health
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.